{"id":"https://openalex.org/W3095338773","doi":"https://doi.org/10.1182/blood-2020-141628","title":"Novel Thyrointegrin \u03b1v\u03b23 Antagonist for the Effective Management of Acute Myeloid Leukemia","display_name":"Novel Thyrointegrin \u03b1v\u03b23 Antagonist for the Effective Management of Acute Myeloid Leukemia","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3095338773","doi":"https://doi.org/10.1182/blood-2020-141628","mag":"3095338773"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-141628","doi":"https://doi.org/10.1182/blood-2020-141628","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141628","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032045966","display_name":"Shaker A. Mousa","orcid":"https://orcid.org/0000-0002-9294-015X","observed_orcids":["https://orcid.org/0000-0002-9294-015X"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaker A Mousa","raw_affiliation_strings":["NanoPharmaceuticals LLC, Rensselaer, NY","The Pharmaceutical Research Institute, ACPHS, Prof, Rensselaer, NY","NanoPharmaceuticals LLC, Rensselaer, NY; The Pharmaceutical Research Institute, ACPHS, Prof, Rensselaer, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanoPharmaceuticals LLC, Rensselaer, NY","institution_ids":[]},{"raw_affiliation_string":"The Pharmaceutical Research Institute, ACPHS, Prof, Rensselaer, NY","institution_ids":["https://openalex.org/I365282"]},{"raw_affiliation_string":"NanoPharmaceuticals LLC, Rensselaer, NY; The Pharmaceutical Research Institute, ACPHS, Prof, Rensselaer, NY","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055493656","display_name":"Noureldien H. E. Darwish","orcid":"https://orcid.org/0000-0002-4124-9772","observed_orcids":["https://orcid.org/0000-0002-4124-9772"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noureldien Darwish","raw_affiliation_strings":["The Pharmaceutical Research Institute, ACPHS, Albany, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Pharmaceutical Research Institute, ACPHS, Albany, NY","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032029811","display_name":"Thangirala Sudha","orcid":"https://orcid.org/0000-0002-6428-1804","observed_orcids":["https://orcid.org/0000-0002-6428-1804"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thangirala Sudha","raw_affiliation_strings":["The Pharmaceutical Research Institute, ACPHS, Rensselaer, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Pharmaceutical Research Institute, ACPHS, Rensselaer, NY","institution_ids":["https://openalex.org/I365282"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I365282"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"5","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.08299999684095383,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/integrin-antagonists","display_name":"integrin antagonists","score":0.9229999780654907},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.8360000252723694},{"id":"https://openalex.org/keywords/metastasis-inhibition","display_name":"metastasis suppression","score":0.656000018119812},{"id":"https://openalex.org/keywords/hematological-remission","display_name":"hematologic remission","score":0.7289999723434448},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.765999972820282},{"id":"https://openalex.org/keywords/bone-marrow-recovery","display_name":"bone marrow recovery","score":0.48100000619888306},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.5669999718666077},{"id":"https://openalex.org/keywords/leukemia-cell-proliferation","display_name":"leukemia cell proliferation","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6507213115692139},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5398011207580566},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5365599989891052},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5023753643035889},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.49133506417274475},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46608230471611023},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4554029703140259},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4376254081726074},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.4341529607772827},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43117600679397583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38694170117378235},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.380569189786911}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-141628","doi":"https://doi.org/10.1182/blood-2020-141628","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141628","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3188530966","https://openalex.org/W4211245413","https://openalex.org/W2915043405","https://openalex.org/W3215538691","https://openalex.org/W3193491660","https://openalex.org/W2999679430","https://openalex.org/W3092634901","https://openalex.org/W2120032851","https://openalex.org/W2030990783","https://openalex.org/W2572987685"],"abstract_inverted_index":{"Acute":[0,483],"myeloid":[1],"leukemia":[2],"is":[3,40],"one":[4],"of":[5,29,45,50,60,85,89,113,145,175,213,236,268,317,356,429,464,476],"the":[6,23,46,110,125,173,234,240,328,375,404,418,471],"most":[7],"aggressive":[8],"malignant":[9],"hematological":[10,311],"disorders":[11],"on":[12,118,352],"worldwide":[13],"basis.":[14],"More":[15],"than":[16],"19,000":[17],"new":[18,31,47],"cases":[19,48],"are":[20,106,130],"estimated":[21,35],"in":[22,26,82,132,187,219,239,392],"United":[24],"States":[25],"2020":[27],"(1.1%":[28],"all":[30,51,88],"cancer":[32,52,214],"cases).":[33],"The":[34,148,362],"death":[36],"rate":[37,59],"from":[38,93,200,279],"AML":[39,67,86,176],"11,180":[41],"that":[42,129,169,414],"represent":[43],"56%":[44],"(1.8%":[49],"death),":[53],"with":[54,161,195,209,288,293,303,314],"an":[55],"overall":[56],"5-year":[57],"survival":[58,218],"27.4%":[61],"[1].":[62],"Current":[63],"treatment":[64,104,194,337,367,377],"regimens":[65],"for":[66,79,109,124,204,261,338,470,482],"include":[68],"traditional":[69],"chemotherapy,":[70],"radiotherapy,":[71],"allogeneic":[72],"hematopoietic":[73],"cell":[74,177,181,270,295,319],"transplantation":[75],"and":[76,96,102,142,164,179,216,229,243,250,256,273,307,321,342,345,359,386,394,398,421,435,444,457,473],"targeted":[77,122],"therapies":[78],"specific":[80],"mutations":[81],"limited":[83],"numbers":[84],"patients,":[87],"whom":[90],"still":[91],"suffer":[92],"adverse":[94],"effects":[95],"relapse.":[97],"New":[98],"broad":[99],"spectrum":[100],"effective":[101,472],"safe":[103,474],"options":[105],"urgently":[107],"needed":[108],"different":[111,324],"types":[112],"AML.":[114,477],"Our":[115,166],"strategy":[116],"focused":[117],"developing":[119],"a":[120],"novel":[121],"therapy":[123],"thyrointegrin":[126,150],"\u03b1v\u03b23":[127,151],"receptors":[128,136],"over-expressed":[131],"leukemic":[133,146,237,269,318],"cells.":[134,147],"This":[135],"support":[137],"adhesion,":[138],"engraftment,":[139],"proliferation,":[140],"invasion/metastasis,":[141],"angiogenesis":[143],"functions":[144,174],"identified":[149],"antagonist":[152],"fluorobenzyl":[153],"Polyethylene":[154],"glycol":[155],"Mono-Triazole":[156],"Tetraiodothyroacetic":[157],"Acid":[158],"(fb-PMT)":[159],"binds":[160],"high":[162],"affinity":[163],"specificity.":[165],"study":[167],"showed":[168],"fb-PMT":[170,196,253,280,363,415,465],"effectively":[171],"suppresses":[172],"line":[178],"primary":[180],"harboring":[182],"FLT3-ITD":[183],"after":[184,330,373],"successful":[185,370],"engraftment":[186,235],"transgenic":[188],"NSG-S":[189],"xenograft":[190],"mouse":[191],"models.":[192,221],"Daily":[193],"at":[197,254,354,360,400],"doses":[198],"ranging":[199],"1-10":[201],"mg/kg,":[202,258],"subcutaneously":[203],"3-4":[205,262],"weeks":[206,263,341],"were":[207,224,283,334,350],"associated":[208],"leukemogenesis":[210],"regression,":[211],"suppression":[212,316],"invasion":[215,322],"extended":[217],"both":[220],"These":[222],"findings":[223,463],"verified":[225],"using":[226,380],"IVIS":[227,343,384],"scanning":[228],"histopathological":[230,387],"examination":[231,349],"to":[232,286],"evaluate":[233,327],"cells":[238,291],"bone":[241],"marrow":[242,298],"other":[244],"organs":[245],"including,":[246,432],"spleen,":[247],"liver,":[248],"lung,":[249],"brain.":[251],"Furthermore,":[252],"3":[255],"10":[257],"s.c.":[259],"daily":[260,376],"exhibited":[264],"significant":[265],"reduction":[266],"(P<0.001)":[267],"burden":[271],"74%":[272],">95%,":[274],"respectively.":[275],"Peripheral":[276],"blood":[277,347,381],"smears":[278],"treated":[281],"animals":[282,353],"reversed":[284],"back":[285],"normal":[287,294,301],"no":[289],"blast":[290],"along":[292,313],"counts.":[296],"Bone":[297],"regain":[299],"its":[300,467],"maturation":[302],"abundant":[304],"segmented":[305],"neutrophil":[306],"megakaryocytes,":[308],"representing":[309],"complete":[310,315],"remission":[312,372],"metastasis":[320],"into":[323],"organs.":[325],"To":[326],"relapse":[329],"treatment,":[331],"40":[332],"mice":[333],"maintained":[335,371],"off":[336,366],"further":[339],"2":[340,442],"scans":[344],"peripheral":[346],"smear":[348,382],"performed":[351],"end":[355],"first":[357],"week":[358],"sacrifice.":[361],"(10":[364],"mg/kg)":[365],"has":[368],"shown":[369],"stopping":[374],"as":[378,425,427],"confirmed":[379],"examination,":[383],"scan,":[385],"examination.":[388],"Additionally,":[389],"safety":[390,397],"assessments":[391],"rodents":[393],"monkeys":[395],"demonstrated":[396,413],"tolerability":[399],"multiple":[401],"folds":[402],"above":[403],"anticipated":[405],"human":[406],"doses.":[407],"Lastly,":[408],"our":[409],"genome-wide":[410],"microarray":[411],"screen":[412],"works":[416],"through":[417],"Hedgehog":[419],"pathway":[420],"Il-21":[422],"receptor":[423],"down-regulation":[424],"well":[426],"downregulation":[428],"several":[430],"genes":[431],"IGF2,":[433],"TWIST1":[434],"FYN":[436],"oncogene,":[437],"angiopoietin":[438],"1":[439,492],"(ANGPT1),":[440],"angiopoietin-like":[441],"(ANGPTL2)":[443],"PIM1":[445],"oncogene":[446],"KIT,":[447],"HRAS,":[448],"INH2,":[449],"BCL,":[450],"AKT1,":[451],"IDH2,":[452],"CDK4/6,":[453],"TIMP1,":[454],"VEGF,":[455],"EGFR":[456],"PD-L1,":[458],"KDM6A,":[459],"EZH2.":[460],"Collectively,":[461],"preclinical":[462],"warrant":[466],"clinical":[468],"investigation":[469],"management":[475],"Reference":[478],"1.":[479],"Key":[480],"Statistics":[481],"Myeloid":[484],"Leukemia":[485],"(AML).":[486],"2020;":[487],"Available":[488],"from:":[489],"https://www.cancer.org/cancer/acute-myeloid-leukemia/about/key-statistics.html.":[490],"Figure":[491],"Disclosures":[493],"Mousa:":[494],"Vascular":[495],"Vision":[496],"Pharma":[497],"Co.:":[498],"Patents":[499],"&":[500],"Royalties.":[501]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2020-11-09T00:00:00"}